Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.

Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.

BACKGROUND AND OBJECTIVE: The long term effects of fingolimod, an oral treatment for relapsing-remitting (RR) multiple sclerosis (MS), on blood circulating B and T cell subtypes in MS patients are not completely understood. This study describes for the first time the longitudinal effects of fingolim...

Descripció completa

Dades bibliogràfiques
Autors principals: Nele Claes, Tessa Dhaeze, Judith Fraussen, Bieke Broux, Bart Van Wijmeersch, Piet Stinissen, Raymond Hupperts, Niels Hellings, Veerle Somers
Format: Article
Idioma:English
Publicat: Public Library of Science (PLoS) 2014-01-01
Col·lecció:PLoS ONE
Accés en línia:http://europepmc.org/articles/PMC4215872?pdf=render

Internet

http://europepmc.org/articles/PMC4215872?pdf=render

Ítems similars